Jacobs Levy Equity Management, Inc Axsome Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$41.2 - $101.31 $1.75 Million - $4.3 Million	-42,438 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$16.71 - $106.24 $531,829 - $3.38 Million	-31,827 Reduced 42.86%	42,438 $4.39 Million
Q1 2019 May 14, 2019	SELL	$2.63 - $16.34 $26,037 - $161,766	-9,900 Reduced 11.76%	74,265 $1.06 Million
Q4 2018 Feb 14, 2019	BUY	$2.0 - $4.15 $41,600 - $86,320	20,800 Added 32.83%	84,165 $237,000
Q3 2018 Nov 14, 2018	BUY	$2.3 - $3.55 $145,739 - $224,945	63,365 New	63,365 $219,000

327

37.7M

912K

855K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.45B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.